picropodophyllin has been researched along with Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bitton-Worms, K; Caspi, A; LeRoith, D; Rostoker, R; Shen-Orr, Z | 1 |
| Guo, W; Tao, ZZ; Yin, SC | 1 |
2 other study(ies) available for picropodophyllin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Investigating new therapeutic strategies targeting hyperinsulinemia's mitogenic effects in a female mouse breast cancer model.
Topics: Animals; Breast Neoplasms; Carcinoma; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Growth Substances; Hyperinsulinism; Insulin; Mammary Neoplasms, Experimental; Mice; Mice, Transgenic; Molecular Targeted Therapy; Peptides; Podophyllotoxin; Receptor, IGF Type 1; Therapies, Investigational | 2013 |
Picropodophyllin inhibits tumor growth of human nasopharyngeal carcinoma in a mouse model.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Phosphorylation; Podophyllotoxin; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Somatomedins; Xenograft Model Antitumor Assays | 2013 |